Login
Israel-Hamas Conflict
Independence Day
Social Media
Formula 1
Donald Trump
Motorsports
Natural Disasters
Floods
World Cup
Infrastructure
Artificial Intelligence
Immigration
Cryptocurrency
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

curetoday.com image

News from curetoday.com

We’ve assigned a media bias rating of unknown to curetoday.com. You can read more about our methodology here.

Information about curetoday.com

Where is curetoday.com located?curetoday.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top curetoday.com News

Mum Stopped Cancer Treatment to 'Live More Fully' - She Died on Sunday
Health

Mum Stopped Cancer Treatment to 'Live More Fully' - She Died on Sunday

Coverage: 17 sources
Laura Dawson decided to stop her treatment and enjoy what time she had left. She died on SundaySee the Story
New Bispecific T-Cell Engager Approved for Multiple Myeloma
Cancer · United States

New Bispecific T-Cell Engager Approved for Multiple Myeloma

83% Center coverage: 6 sources
(MedPage Today) -- The FDA on Wednesday granted accelerated approval to linvoseltamab (Lynozyfic) for relapsed or refractory multiple myeloma after at least four prior lines of therapy. A B-cell maturation antigen (BCMA)-directed bispecific antibody...See the Story
New strategy enhances immunotherapy effectiveness against glioblastoma by utilizing gut microbes
Medical

New strategy enhances immunotherapy effectiveness against glioblastoma by utilizing gut microbes

100% Center coverage: 3 sources
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy as standalone therapies for glioblastoma, the most lethal form of brain tumor.See the Story

AI Tool Accurately Predicts Prostate Cancer Outcomes Across Racial Groups

Mack Roach III, MD, discusses the development and evaluation of a multimodal AI algorithm designed to predict prostate cancer outcomes and its performance across racial subgroups.HealthcareSee the Story

CAR-T Therapy Dilemma and Innovative Design Strategies for Next Generation

100% Center coverage: 2 sources
Chimeric antigen receptor (CAR)-T-cell therapy has shown remarkable curative effects on hematological tumors, driving the exponential growth in CAR-T-related research. Although CD19-targeting CAR-T-cell therapy has displayed remarkable promise in clinical trials, many obstacles are arising that limit its therapeutic efficacy in tumor immunotherapy. The “dilemma” of CAR-T cell-based tumor therapy includes lethal cytotoxicity, restricted trafficki…Milan, Lombardy · MilanSee the Story

Broken Yet Unbreakable: My Previvor Journey and the Power of Symbolism

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, and honor my journey with purpose.Read Article

My Imaginary Fear of Cancer Recurrence

Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.Read Article

A New Frontier in Melanoma Treatment

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) therapy.Read Article

Reflections After Nine Years as a Bladder Cancer Survivor

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.Read Article

Thermo Fisher’s NGS Assay Receives FDA Approval as a Companion Diagnostic for ZEGFROVY and for Tumor Profiling

100% Center coverage: 1 sources
CARLSBAD, Calif.--(BUSINESS WIRE)--Jul 3, 2025-United States · United StatesSee the Story

Tipping My Hat to the Heroes of the Cancer Community

Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!Read Article

Breaking News Topics Related to curetoday.com

Cancer icon

Cancer

Breast Cancer icon

Breast Cancer

United States icon

United States

Medical icon

Medical

News
For You
SearchBlindspotLocal